Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019
Increased research and development efforts have greatly contributed to the growth of the immunoprotein diagnostic testing market in recent years, states a recent report published by Transparency Market Research. The report, titled “Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, indicates that, registering a CAGR of 5.7% from 2013 and 2019, the global immunoprotein diagnostic testing market stands to expand from US$11,019.7 million in 2012 to US$15,351.0 million in 2019.
Increased research and development efforts have greatly contributed to the growth of the immunoprotein diagnostic testing market in recent years, states a recent report published by Transparency Market Research. The report, titled “Immunoprotein Diagnostic Testing Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, indicates that, registering a CAGR of 5.7% from 2013 and 2019, the global immunoprotein diagnostic testing market stands to expand from US$11,019.7 million in 2012 to US$15,351.0 million in 2019.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Transparency <strong>Market</strong><br />
Research<br />
<strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> - <strong>Global</strong><br />
<strong>Industry</strong> <strong>Analysis</strong>, <strong>Size</strong>, <strong>Share</strong>, <strong>Growth</strong>, <strong>Trends</strong> <strong>and</strong><br />
<strong>Forecast</strong>, <strong>2013</strong> - <strong>2019</strong><br />
Published Date<br />
2014-04-24<br />
96 Page Report<br />
Buy Now<br />
Request Sample<br />
Press Release<br />
<strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Driven by Urgent Need<br />
for Preventive Healthcare in Emerging Economies<br />
Transparency <strong>Market</strong> Research<br />
State Tower,<br />
90, State Street, Suite 700.<br />
Albany, NY 12207<br />
United States<br />
www.transparencymarketresearch.com<br />
sales@transparencymarketresearch.com
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
REPORT DESCRIPTION<br />
<strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> - <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong>, <strong>Size</strong>,<br />
<strong>Share</strong>, <strong>Growth</strong>, <strong>Trends</strong> <strong>and</strong> <strong>Forecast</strong>, <strong>2013</strong> <strong>–</strong> <strong>2019</strong><br />
Increased research <strong>and</strong> development efforts have greatly contributed to the growth of the<br />
immunoprotein diagnostic testing market in recent years, states a recent report published by<br />
Transparency <strong>Market</strong> Research. The report, titled “<strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong><br />
- <strong>Global</strong> <strong>Industry</strong> <strong>Analysis</strong>, <strong>Size</strong>, <strong>Share</strong>, <strong>Growth</strong>, <strong>Trends</strong> <strong>and</strong> <strong>Forecast</strong>, <strong>2013</strong> - <strong>2019</strong>”,<br />
indicates that, registering a CAGR of 5.7% from <strong>2013</strong> <strong>and</strong> <strong>2019</strong>, the global immunoprotein<br />
diagnostic testing market st<strong>and</strong>s to exp<strong>and</strong> from US$11,019.7 million in 2012 to US$15,351.0<br />
million in <strong>2019</strong>.<br />
The research report segments the global immunoprotein diagnostic testing market on the basis<br />
of assay technology, immunoprotein type, application, <strong>and</strong> geography. By the type of<br />
immunoprotein tested, the market is categorized into C-reactive protein diagnostic tests, free<br />
light chain diagnostic tests, prealbumin diagnostic tests, complement system protein diagnostic<br />
tests, immunoglobulin diagnostic tests, <strong>and</strong> haptoglobin diagnostic tests. The C-reactive protein<br />
diagnostic test has been the largest segment owing to its effective <strong>and</strong> accurate diagnosis of<br />
injuries, inflammation-related disorders, strokes, <strong>and</strong> cardiovascular diseases. However, analysts<br />
believe that, being in the initial stages of development, the segment of free light chain diagnostic<br />
tests is likely to pick up pace in the near future.<br />
Browse the full <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Report<br />
@ :http://www.transparencymarketresearch.com/immunoprotein-diagnostictesting.html<br />
On the basis of technology, the market for immunoprotein diagnostic testing is segmented into<br />
enzyme-based immunoassay, radioimmunoassay, chemiluminescence assay,<br />
immunofluorescence assay, immunoprotein electrophoresis, <strong>and</strong> immunoturbidity assay. The<br />
chemiluminecence assay segment dominated the global immunoprotein diagnostic testing<br />
market in 2012, due to its feasibility for wide-scale application, sensitivity, safety, <strong>and</strong> ease of<br />
use. The segment of radioimmunoassay testing has been losing market share over the years<br />
owing to high cost of equipment <strong>and</strong> devices, strict healthcare regulations, <strong>and</strong> high exposure to<br />
radiation. Doctors <strong>and</strong> clinicians have switched to safer <strong>and</strong> more effective tests, leading to a<br />
decline in the radioimmunoassay testing market.<br />
Transparency <strong>Market</strong> Research<br />
2
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
Browse the full <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Press Release<br />
@ :http://www.transparencymarketresearch.com/pressrelease/immunoproteindiagnostic-testing.htm<br />
<strong>Immunoprotein</strong> diagnostic testing finds application in endocrine testing, allergy testing,<br />
infectious diseases, toxicology testing, oncology testing, <strong>and</strong> autoimmune disease testing. The<br />
report indicates that the segment of oncology testing will generate maximum revenue by the<br />
end of the forecast period, presenting a market worth of US$4,943.0 million in <strong>2019</strong> <strong>and</strong> growing<br />
at a CAGR of 6% from <strong>2013</strong> to <strong>2019</strong>.The report identifies some of the major factors governing the<br />
growth of the immunoprotein diagnostic testing market. According to the report, the growing<br />
dem<strong>and</strong> for quick, accurate, <strong>and</strong> preventive healthcare <strong>–</strong> especially in emerging economies <strong>–</strong> is a<br />
primary factor boosting the global market. In addition, technological development,<br />
commoditization of products, expansion in the field of immunochromatography, <strong>and</strong><br />
strengthening network of distributors at a global level has also contributed to the growth of the<br />
immunoprotein diagnostic testing market. In contrast, high cost of diagnosis is likely to restrict<br />
the development of this market over the forecast period.<br />
Some of the leading players in the global immunoprotein diagnostic testing market are DiaSorin<br />
SPA, Thermo Fisher Scientific, Inc., The Binding Site Group Ltd., Abcam PLC, Omega <strong>Diagnostic</strong>s<br />
Group PLC, R<strong>and</strong>ox Laboratories Ltd., Siemens AG, Enzo Life Sciences, Inc., Roche Holding AG,<br />
Fujirebio <strong>Diagnostic</strong>s, Inc., <strong>and</strong> Abbott Laboratories, Inc. These players are profiled on the basis of<br />
parameters such as company <strong>and</strong> financial overview, recent developments, product portfolio,<br />
business strategies, <strong>and</strong> a SWOT analysis.<br />
Get Free Sample Report :<br />
http://www.transparencymarketresearch.com/sample/sample.php?<br />
flag=s&rep_id=1253<br />
TABLE OF CONTENT<br />
Table of Content<br />
Chapter 1 Introduction<br />
Transparency <strong>Market</strong> Research<br />
3
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
1.1 Report Description<br />
1.2 <strong>Market</strong> Segmentation<br />
1.3 Research Methodology<br />
1.3.1 Secondary Research<br />
1.3.2 Primary Research<br />
1.4 List of Abbreviations<br />
1.5 Assumptions <strong>and</strong> Stipulations<br />
Chapter 2 Executive Summary<br />
Chapter 3 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Overview<br />
3.1 Introduction<br />
3.2 <strong>Market</strong> <strong>Trends</strong> <strong>and</strong> Future Outlook<br />
3.3 <strong>Market</strong> Dynamics<br />
3.3.1 Drivers<br />
3.3.1.1 Rising need for quick <strong>and</strong> accurate disease diagnosis<br />
3.3.1.2 Technological advancement<br />
3.3.1.3 Rising dem<strong>and</strong> for preventive healthcare in developing economies<br />
3.3.1.4 Strong network of distributors across the globe<br />
3.3.1.5 Commoditization of products<br />
Transparency <strong>Market</strong> Research<br />
4
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
3.3.2 Restraints<br />
3.3.2.1 Higher cost of diagnosis<br />
3.3.2.2 Installed base of traditional ELISA<br />
3.3.3 Opportunities<br />
3.3.3.1 Immunochromatography<br />
3.3.3.2 Research <strong>and</strong> development<br />
3.3.3.3 Expansion in emerging economies<br />
3.1 Porter’s Five Force <strong>Analysis</strong> for the <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong><br />
3.1.1 Bargaining Power of Suppliers<br />
3.1.2 Bargaining Power of Buyers<br />
3.1.3 Threat of Substitutes<br />
3.1.4 Threat of New Entrants<br />
3.1.5 Competitive Rivalry<br />
3.2 <strong>Market</strong> Attractiveness <strong>Analysis</strong> for the <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong>, by<br />
Geography<br />
3.3 Heat Map <strong>Analysis</strong>: <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong><br />
3.3.1 Methodology<br />
3.3.2 Heat Map <strong>Analysis</strong> for the <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong>, by key<br />
players, 2012<br />
Transparency <strong>Market</strong> Research<br />
5
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
Chapter 4 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong>, by Assay Technology<br />
4.1 Introduction<br />
4.1.1 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Assay Technology, 2011<br />
- <strong>2019</strong> (USD Million)<br />
4.2 Radioimmunoassay<br />
4.2.1 <strong>Global</strong> Radioimmunoassay <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
4.3 Enzyme Based Immunoassay<br />
4.3.1 <strong>Global</strong> Enzyme Based Immunoassay <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
4.4 Chemiluminescence Assay<br />
4.4.1 <strong>Global</strong> Chemiluminescence Assay <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
4.5 Immunofluorescence Assay<br />
4.5.1 <strong>Global</strong> Immunofluorescence Assay <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
4.6 Immunoturbidity Assay<br />
4.6.1 <strong>Global</strong> Immunoturbidity Assay <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
4.7 <strong>Immunoprotein</strong> Electrophoresis<br />
4.7.1 <strong>Global</strong> <strong>Immunoprotein</strong> Electrophoresis Assay <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD<br />
Million)<br />
Chapter 5 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong>, by <strong>Immunoprotein</strong> Type<br />
5.1 Introduction<br />
Transparency <strong>Market</strong> Research<br />
6
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
5.1.1 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by <strong>Immunoprotein</strong> Type,<br />
2011 - <strong>2019</strong> (USD Million)<br />
5.2 Complement System Proteins <strong>Diagnostic</strong> Tests<br />
5.2.1 <strong>Global</strong> Complement System Protein <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong><br />
(USD Million)<br />
5.3 Free Light Chain <strong>Diagnostic</strong> Tests<br />
5.3.1 <strong>Global</strong> Free Light Chain <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
5.4 Haptoglobin <strong>Diagnostic</strong> Tests<br />
5.4.1 <strong>Global</strong> Haptoglobin <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
5.5 Immunoglobulin <strong>Diagnostic</strong> Tests<br />
5.5.1 <strong>Global</strong> Immunoglobulin <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
5.6 Prealbumin <strong>Diagnostic</strong> Tests<br />
5.6.1 <strong>Global</strong> Prealbumin <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
5.7 C-Reactive Protein (CRP) <strong>Diagnostic</strong> Tests<br />
5.7.1 <strong>Global</strong> C-Reactive Protein <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
Chapter 6 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong>, by Application<br />
6.1 Introduction<br />
6.1.1 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Application, 2011 -<br />
<strong>2019</strong> (USD Million)<br />
6.2 Infectious Disease <strong>Testing</strong><br />
Transparency <strong>Market</strong> Research<br />
7
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
6.2.1 <strong>Global</strong> Infectious Disease <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
6.3 Oncology <strong>Testing</strong><br />
6.3.1 <strong>Global</strong> Oncology <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
6.4 Endocrine <strong>Testing</strong><br />
6.4.1 <strong>Global</strong> Endocrine <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
6.5 Toxicology <strong>Testing</strong><br />
6.5.1 <strong>Global</strong> Toxicology <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
6.6 Allergy <strong>Testing</strong><br />
6.6.1 <strong>Global</strong> Allergy <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
6.7 Autoimmune Disease <strong>Testing</strong><br />
6.7.1 <strong>Global</strong> Autoimmune Disease <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
Chapter 7 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong>, by Geography<br />
7.1 Introduction<br />
7.1.1 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Geography, 2011 <strong>–</strong><br />
<strong>2019</strong> (USD Million)<br />
7.2 North America<br />
7.2.1 North America <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Assay<br />
Technology, 2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
7.3 Europe<br />
Transparency <strong>Market</strong> Research<br />
8
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
7.3.1 Europe <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Assay Technology,<br />
2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
7.4 Asia-Pacific<br />
7.4.1 Asia-Pacific <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Assay Technology,<br />
2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
7.5 Rest of the World (RoW)<br />
7.5.1 Rest of the World <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Assay<br />
Technology, 2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
Chapter 8 Recommendations<br />
8.1 Untapped allergy testing market<br />
8.2 Future of oncology testing<br />
8.3 Upgrading to latest technology<br />
Chapter 9 Company Profiles<br />
9.1 Abbott Laboratories, Inc.<br />
9.1.1 Company Overview<br />
9.1.2 Financial Overview<br />
9.1.3 Product Portfolio<br />
9.1.4 Business Strategies<br />
9.1.5 Recent Developments<br />
Transparency <strong>Market</strong> Research<br />
9
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
9.2 Abcam PLC<br />
9.2.1 Company Overview<br />
9.2.2 Financial Overview<br />
9.2.3 Product Portfolio<br />
9.2.4 Business Strategies<br />
9.2.5 Recent Developments<br />
9.3 DiaSorin SPA<br />
9.3.1 Company Overview<br />
9.3.2 Financial Overview<br />
9.3.3 Product Portfolio<br />
9.3.4 Business Strategies<br />
9.3.5 Recent Developments<br />
9.4 Enzo Life Sciences, Inc.<br />
9.4.1 Company Overview<br />
9.4.2 Financial Overview<br />
9.4.3 Product Portfolio<br />
9.4.4 Business Strategies<br />
9.4.5 Recent Developments<br />
9.5 Fujirebio <strong>Diagnostic</strong>s, Inc.<br />
9.5.1 Company Overview<br />
Transparency <strong>Market</strong> Research<br />
10
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
9.5.2 Financial Overview<br />
9.5.3 Product Portfolio<br />
9.5.4 Business Strategies<br />
9.5.5 Recent Developments<br />
9.6 Omega <strong>Diagnostic</strong>s Group PLC<br />
9.6.1 Company Overview<br />
9.6.2 Financial Overview<br />
9.6.3 Product Portfolio<br />
9.6.4 Business Strategies<br />
9.6.5 Recent Developments<br />
9.7 R<strong>and</strong>ox Laboratories Ltd.<br />
9.7.1 Company Overview<br />
9.7.2 Financial Overview<br />
9.7.3 Product Portfolio<br />
9.7.4 Business Strategies<br />
9.7.5 Recent Developments<br />
9.8 Roche Holding AG<br />
9.8.1 Company Overview<br />
9.8.2 Financial Overview<br />
9.8.3 Product Portfolio<br />
Transparency <strong>Market</strong> Research<br />
11
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
9.8.4 Business Strategies<br />
9.8.5 Recent Developments<br />
9.9 Siemens AG<br />
9.9.1 Company Overview<br />
9.9.2 Financial Overview<br />
9.9.3 Product Portfolio<br />
9.9.4 Business Strategies<br />
9.9.5 Recent Developments<br />
9.10 The Binding Site Group Ltd.<br />
9.10.1 Company Overview<br />
9.10.2 Financial Overview<br />
9.10.3 Product Portfolio<br />
9.10.4 Business Strategies<br />
9.10.5 Recent Developments<br />
9.11 Thermo Fisher Scientific, Inc.<br />
9.11.1 Company Overview<br />
9.11.2 Financial Overview<br />
9.11.3 Product Portfolio<br />
9.11.4 Business Strategies<br />
9.11.5 Recent Developments<br />
Transparency <strong>Market</strong> Research<br />
12
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
List of Figures<br />
FIG. 1 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> <strong>–</strong> <strong>Market</strong> Segmentation<br />
FIG. 2 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, 2011-<strong>2019</strong> (USD Million)<br />
FIG. 3 Porter’s Five Force <strong>Analysis</strong>: <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong><br />
FIG. 4 <strong>Market</strong> Attractiveness <strong>Analysis</strong>: <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong>, by<br />
Geography<br />
FIG. 5 Heat Map <strong>Analysis</strong>: <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong>, by Key Players<br />
(2012)<br />
FIG. 6 <strong>Global</strong> Radioimmunoassay <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 7 <strong>Global</strong> Enzyme Based Immunoassay <strong>Market</strong> Revenue, 2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 8 <strong>Global</strong> Chemiluminescence Assay <strong>Market</strong> Revenue, 2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 9 <strong>Global</strong> Immunofluorescence Assay <strong>Market</strong> Revenue, 2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 10 <strong>Global</strong> Immunoturbidity Assay <strong>Market</strong> Revenue, 2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
FIG. 11 <strong>Global</strong> <strong>Immunoprotein</strong> Electrophoresis Assay <strong>Market</strong> Revenue, 2011 <strong>–</strong> <strong>2019</strong> (USD<br />
Million)<br />
FIG. 12 <strong>Global</strong> Complement System Protein <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong><br />
(USD Million)<br />
FIG. 13 <strong>Global</strong> Free Light Chain <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 14 <strong>Global</strong> Haptoglobin <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 15 <strong>Global</strong> Immunoglobulin <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
Transparency <strong>Market</strong> Research<br />
13
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
FIG. 16 <strong>Global</strong> Prealbumin Dagnostic Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 17 <strong>Global</strong> C-Reactive Protein <strong>Diagnostic</strong> Tests <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 18 <strong>Global</strong> Infectious Disease <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 19 <strong>Global</strong> Oncology <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 20 <strong>Global</strong> Endocrine <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 21 <strong>Global</strong> Toxicology <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 22 <strong>Global</strong> Allergy <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 23 <strong>Global</strong> Autoimmune Disease <strong>Testing</strong> <strong>Market</strong> Revenue, 2011 - <strong>2019</strong> (USD Million)<br />
FIG. 24 Abbott Laboratories, Inc.: Annual Revenue, 2010 <strong>–</strong> 2012 (USD Million)<br />
FIG. 25 Abcam PLC: Annual Revenue, 2010 <strong>–</strong> 2012 (USD Million)<br />
FIG. 26 DiaSorin SPA: Annual Revenue, 2010 <strong>–</strong> 2012 (USD Million)<br />
FIG. 27 Omega <strong>Diagnostic</strong>s Group PLC: Annual Revenue, 2010 <strong>–</strong> 2012 (USD Million)<br />
FIG. 28 Roche Holding AG: Annual Revenue, 2010 <strong>–</strong> 2012 (USD Million)<br />
FIG. 29 Siemens AG (Healthcare Segment): Annual Revenue, 2010 <strong>–</strong> 2012 (USD Million)<br />
FIG. 30 Thermo Fisher Scientific, Inc.: Annual Revenue, 2010 <strong>–</strong> 2012 (USD Million)<br />
List of Tables<br />
TABLE 1 <strong>Market</strong> Snapshot: <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong><br />
TABLE 2 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Assay Technology, 2011<br />
- <strong>2019</strong> (USD Million)<br />
Transparency <strong>Market</strong> Research<br />
14
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
TABLE 3 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by <strong>Immunoprotein</strong> Type,<br />
2011 - <strong>2019</strong> (USD Million)<br />
TABLE 4 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Application, 2011 - <strong>2019</strong><br />
(USD Million)<br />
TABLE 5 <strong>Global</strong> <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Geography, 2011 <strong>–</strong> <strong>2019</strong><br />
(USD Million)<br />
TABLE 6 North America <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Assay<br />
Technology, 2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
TABLE 7 Europe <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Assay Technology, 2011<br />
<strong>–</strong> <strong>2019</strong> (USD Million)<br />
TABLE 8 Asia-Pacific <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Assay Technology,<br />
2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
TABLE 9 Rest of the World <strong>Immunoprotein</strong> <strong>Diagnostic</strong> <strong>Testing</strong> <strong>Market</strong> Revenue, by Assay<br />
Technology, 2011 <strong>–</strong> <strong>2019</strong> (USD Million)<br />
Browse All Biotechnology <strong>Market</strong> Research Reports @<br />
http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html<br />
About Us<br />
Transparency <strong>Market</strong> Research is a market intelligence company providing global business information<br />
reports <strong>and</strong> services. Our exclusive blend of quantitative forecasting <strong>and</strong> trends analysis provides forwardlooking<br />
insight for thous<strong>and</strong>s of decision makers.<br />
We are privileged with highly experienced team of Analysts, Researchers <strong>and</strong> Consultants, who use<br />
proprietary data sources <strong>and</strong> various tools <strong>and</strong> techniques to gather, <strong>and</strong> analyze information. Our<br />
Transparency <strong>Market</strong> Research<br />
15
<strong>Immunoprotein</strong> <strong>Diagnostic</strong><br />
<strong>Testing</strong> <strong>Market</strong><br />
business offerings represent the latest <strong>and</strong> the most reliable information indispensable for businesses to<br />
sustain a competitive edge.<br />
Contact<br />
Transparency <strong>Market</strong> Research<br />
90 State Street,<br />
Suite 700,<br />
Albany<br />
NY - 12207<br />
United States<br />
Tel: +1-518-618-1030<br />
USA - Canada Toll Free 866-552-3453<br />
Email: sales@transparencymarketresearch.com<br />
Website: http://www.transparencymarketresearch.com/<br />
Transparency <strong>Market</strong> Research<br />
16
Change language